Effect of pulsed radiofrequency in treatment of facet-joint origin back pain in patients with degenerative spondylolisthesis

Background Degenerative spondylolisthesis is a well-recognized source of low back pain mainly induced by facet joint pain. Pulsed radiofrequency (PRF) allows heat dissipation, thus producing a temporary injury that affects only type C fibers responsible for pain conduction. Objectives We attempted t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European spine journal 2014-09, Vol.23 (9), p.1927-1932
Hauptverfasser: Hashemi, Masoud, Hashemian, Morteza, Mohajerani, Seyed Amir, Sharifi, Giv
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Degenerative spondylolisthesis is a well-recognized source of low back pain mainly induced by facet joint pain. Pulsed radiofrequency (PRF) allows heat dissipation, thus producing a temporary injury that affects only type C fibers responsible for pain conduction. Objectives We attempted to test whether PRF is a better choice for facet pain due to spondylolisthesis compared to routine steroid injection. Methods Patients were randomly assigned to one of two groups: group one received pulsed RF, and group 2 received injection by steroids (triamcinolone) and bupivacaine. Outcomes assessment Multiple outcome measures were utilized which included the numeric rating scale (NRS), the Oswestry Disability Index (ODI), satisfaction status, and analgesic intake with assessment at 3, 6, and 12 months post-treatment. Significant pain relief was defined as 50 % or more, whereas significant improvement in disability score was defined as reduction of 40 % or more. Results Eighty patients were enrolled in the study and were divided into the two groups of study. PRF significantly reduced NRS at 6-month follow-up compared to steroid + bupivacaine. 75.6 ± 14.3 % at pre-treatment and 19.3 ± 9.5 % at 6 months ( p  = 0.001) in PRF group. The mean ODI is depicted in two groups of study (Fig.  1 ). Interestingly, ODI% was significantly lower in PRF group at 12 weeks and 6 months compare to steroid + bupivacaine group ( p  = 0.022 and 0.03, respectively), but it was not significantly different at 6 weeks ( p  = 0.31). Proportion of patients who did not require analgesics were significantly higher in PRF group compared to other group ( p  = 0.001) in Log-rank (Mantel–Cox) test. Conclusion Our results demonstrated that the application of PRF might be more effective than steroid and bupivacaine injection in decreasing back pain due to degenerative facet pain and improvement in function of patients.
ISSN:0940-6719
1432-0932
DOI:10.1007/s00586-014-3412-x